Mucosal adjuvanticity of a shigella invasin complex with DNA-Based vaccines

Clinical and Vaccine Immunology

Volumn 16, Issue 4, 2009, Pages 574-586

  Kaminski, Robert W ^a   Turbyfill, K Ross ^a   Chao, C ^b   Ching, W M ^b   Oaks, Edwin V ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN A; IMMUNOLOGICAL ADJUVANT; INVAPLEX; INVASIN; MONOCLONAL ANTIBODY IPAB; MONOCLONAL ANTIBODY IPAC; PLASMID DNA; PROTEIN R56KARP; SHIGELLA VACCINE; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; COMPLEX FORMATION; CONTROLLED STUDY; DNA TRANSFECTION; EUKARYOTE; IMMUNOGENICITY; MAMMAL CELL; MICROTUBULE ASSEMBLY; MOUSE; NONHUMAN; ORIENTIA TSUTSUGAMUSHI; PHAGOCYTOSIS; PRIORITY JOURNAL; SHIGELLA; VACCINE PRODUCTION;

ADHESINS, BACTERIAL; ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; CELL LINE; CRICETINAE; ENDOCYTOSIS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN A; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED BALB C; MUCOUS MEMBRANE; ORIENTIA TSUTSUGAMUSHI; SHIGELLA; VACCINES, DNA;

EID: 64549146227     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00435-08     Document Type: Article

References (53)

1. Akashi, S., R. Shimazu, H. Ogata, Y. Nagai, K. Takeda, M. Kimoto, and K Miyake. 2000. Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J. Immunol. 164:3471-3475.
2. Bourdet-Sicard, R., M. Rudiger, B. M. Jockusch, P. Gounon, P. J. Sansonetti, and G. T. Nhieu. 1999. Binding of the Shigella protein IpaA to vinculin induces F-actin depolymerization. EMBO J. 18:5853-5862.
3. Buysse, J. M., C. K. Stover, E. V. Oaks, M. Venkatesan, and D. J. Kopecko. 1987. Molecular cloning of invasion plasmid antigen (ipa) genes from Shi-gella flexneri: analysis of ipa gene products and genetic mapping. J. Bacteriol. 169:2561-2569.
4. Chen, W., Y. Lin, C. Liao, and S. Hsieh. 2000. Modulatory effects of the human heat shock protein 70 on DNA vaccination. J. Biomed. Sci. 7:412 419.
5. Cui, Z., and R. J. Mumper. 2003. Microparticles and nanoparticles as delivery systems for DNA vaccines. Crit. Rev. Ther. Drug Carrier Syst. 20:103-137.
6. Donnelly, J. J., M. A. Liu, and J. B. Ulmer. 2000. Antigen presentation and DNA vaccines. Am. J. Respir. Crit. Care Med. 162:S190-193.
7. Felgner, P. L., T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold, and M. Danielsen. 1987. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. uSA 84:7413-7417.
8. Finlay, B. B., and S. Falkow. 1988. Comparison of the invasion strategies used by Salmonella cholerae-suis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication. Biochimie 70:1089-1099.
9. Greenland, J. R., and N. L. Letvin. 2007. Chemical adjuvants for plasmid DNA vaccines. Vaccine 25:3731-3741.
10. Gurunathan, S., D. M. Klinman, and R. A. Seder. 2000. DNA vaccines: immunology, application, and optimization*. Annu. Rev. Immunol. 18:927-74.
11. Hale, T. L., R. E. Morris, and P. F. Bonventre. 1979. Shigella infection of Henle intestinal epithelial cells: role of the host cell. Infect. Immun. 24:887-894.
12. Hartman, A. B., L. L. Van de Verg, C. R. Mainhart, B. D. Tall, and S. J. Smith-Gill. 1996. Specificity of monoclonal antibodies elicited by mucosal infection of BALB/c mice with virulent Shigella flexneri 2a. Clin. Diagn. Lab Immunol. 3:584-589.
13. High, N., J. Mounier, M. C. Prevost, and P. J. Sansonetti. 1992. IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole. EMBO J. 11:1991-1999.
14. Kaminski, R. W., L. F. Lee, K. R. Turbyfill, D. Scott, P. Guerry, and E. V. Oaks. 2003. Shigella Invaplex enhances cellular and humoral immune responses to Campylobacter FlaA protein: potential for enteric combination vaccine, abstr. P12. Presented at the Sixth Annual Conference on Vaccine Research, Arlington, VA.
15. aminski, R. W., K. R. Turbyfill, and E. V. Oaks. 2006. Mucosal adjuvant properties of the Shigella invasin complex. Infect. Immun. 74:2856-2866.
16. anellos, T. S., D. K. Byarugaba, P. H. Russell, C. R. Howard, and C. D. artidos. 2000. Naked DNA when co-administered intranasally with heatlabile enterotoxin of Escherichia coli primes effectively for systemic B-and T-cell responses to the encoded antigen. Immunol. Lett. 74:215-220.
17. Kano, T., T. Abe, H. Tomita, T. Sakata, S. Ishiguro, and M. Tamai. 2002. Protective effect against ischemia and light damage of iris pigment epithelial cells transfected with the BDNF gene. Investig. Ophthalmol. Vis. Sci. 43: 3744-3753.
18. Kersten, G., and H. Hirschberg. 2004. Antigen delivery systems. Expert Rev. Vaccines 3:453-462.
19. Khatri, K., A. K. Goyal, P. N. Gupta, N. Mishra, A. Mehta, and S. P. Vyas. 2008. Surface modified liposomes for nasal delivery of DNA vaccine. Vaccine 26:2225-2233.
20. Kuklin, N., M. Daheshia, K. Karem, E. Manickan, and B. T. Rouse. 1997. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71:3138-3145.
21. Li, X., X. Yang, L. Li, H. Liu, and J. Liu. 2006. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine. Vaccine 24:3321-3331.
22. Lu, S., S. Wang, and J. M. Grimes-Serrano. 2008. Current progress of DNA vaccine studies in humans. Expert Rev. Vaccines 7:175-191.
23. Marquart, M. E., W. L. Picking, and W. D. Picking. 1996. Soluble invasion plasmid antigen C (IpaC) from Shigella flexneri elicits epithelial cell responses related to pathogen invasion. Infect. Immun. 64:4182-4187.
24. Menard, R., M. C. Prevost, P. Gounon, P. Sansonetti, and C. Dehio. 1996. The secreted Ipa complex of Shigella flexneri promotes entry into mammalian cells. Proc. Natl. Acad. Sci. uSA 93:1254-1258.
25. Menard, R., P. Sansonetti, and C. Parsot. 1994. The secretion ofthe Shigella flexneri Ipa invasins is activated by epithelial cells and controlled by IpaB and IpaD. EMBO J. 13:5293-5302.
26. Menard, R., P. J. Sansonetti, and C. Parsot. 1993. Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J. Bacteriol. 175:5899-5906.
27. Mills, J. A., J. M. Buysse, and E. V. Oaks. 1988. Shigella flexneri invasion plasmid antigens B and C: epitope location and characterization with monoclonal antibodies. Infect. Immun. 56:2933-2941.
28. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
29. Ni, Y. S., T. C. Chan, C. C. Chao, A. L. Richards, G. A. Dasch, and W. M. Ching. 2005. Protection against scrub typhus by a plasmid vaccine encoding the 56-KD outer membrane protein antigen gene. Am. J. Trop. Med. Hyg. 73:936-941.
30. Oaks, E. V., C. K. Stover, and R. M. Rice. 1987. Molecular cloning and expression of Rickettsia tsutsugamushi genes for two major protein antigens in Escherichia coli. Infect. Immun. 55:1156-1162.
31. Oaks, E. V., and K. R. Turbyfill. 2006. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine. Vaccine 24:2290-2301.
32. Oaks, E. V., K. R. Turbyfill, W. Byrd, and F. J. Cassels. 2002. Immunoge-nicity and efficacy of a novel Shigella invasin complex/ETEC colonization factor bivalent vaccine in mice, abstr. S48. Presented at the The Fifth Annual Conference on Vaccine Research, Baltimore, MD.
33. Page, A. L., H. Ohayon, P. J. Sansonetti, and C. Parsot. 1999. The secreted IpaB and IpaC invasins and their cytoplasmic chaperone IpgC are required for intercellular dissemination of Shigella flexneri. Cell. Microbiol. 1:183-193.
34. Planelles, L., M. C. Thomas, C. Alonso, and M. C. Lopez. 2001. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect. Immun. 69:6558-6563.
35. Pulendran, B. 2004. Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol. Rev. 199:227-250.
36. Rao, M., and C. R. Alving. 2000. Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. Adv. Drug Deliv. Rev. 41:171-188.
37. Robinson, H. L. 1997. DNA vaccines for immunodeficiency viruses. AIDS 11(Suppl. A):S109-S119.
38. Sansonetti, P. J. 1991. Geneticand molecularbasis ofepithelialcellinvasion by Shigella species. Rev. Infect. Dis. 13(Suppl. 4):S285-S292.
39. Sasaki, S., K. Hamajima, J. Fukushima, A. Ihata, N. Ishii, I. Gorai, F. Hirahara, H. Mohri, and K. Okuda 1998. Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine. Infect. Immun. 66: 823-826.
40. Sasaki, S., K. Sumino, K. Hamajima, J. Fukushima, N. Ishii, S. Kawamoto, H. Mohri, C. R. Kensil, and K. Okuda. 1998. Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes. J. Virol. 72:4931-4939.
41. Sasaki, S., T. Tsuji, K. Hamajima, J. Fukushima, N. Ishii, T. Kaneko, K. Q. Xin, H. Mohri, I. Aoki, T. Okubo, K. Nishioka, and K. Okuda. 1997. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1. Infect. Immun. 65:3520-3528.
42. Sato, Y., M. Roman, H. Tighe, D. Lee, M. Corr, M. D. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352-354.
43. Schroeder, G. N., and H. Hilbi. 2008. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin. Microbiol. Rev. 21:134-156.
44. Stover, C. K., D. P. Marana, J. M. Carter, B. A. Roe, E. Mardis, and E. V. Oaks. 1990. The 56-kilodalton major protein antigen of Rickettsia tsutsugamushi: molecular cloning and sequence analysis of the Sta56 gene and precise identification of a strain-specific epitope. Infect. Immun. 58:2076-2084.
45. Tran Van Nhieu, G., E. Caron, A. Hall, and P. J. Sansonetti. 1999. IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells. EMBO J. 18:3249-3262.
46. Turbyfill, K. R., A. B. Hartman, and E. V. Oaks. 2000. Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine. Infect. Immun. 68:6624-6632.
47. Ulmer, J. B., C. M. DeWitt, M. Chastain, A. Friedman, J. J. Donnelly, W. L. McClements, M. J. Caulfield, K. E. Bohannon, D. B. Volkin, and R. K Evans. 1999. Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine 18:18-28.
48. Virtanen, I., P. Ekblom, and P. Laurila. 1980. Subcellular compartmentalization of saccharide moieties in cultured normal and malignant cells. J. Cell Biol. 85:429-434.
49. Watarai, M., T. Tobe, M. Yoshikawa, and C. Sasakawa 1995. Contact of Shigella with host cells triggers release of Ipa invasins and is an essential function of invasiveness. EMBO J. 14:2461-2470.
50. Yasuyoshi, H., S. Kashii, M. Kikuchi, S. Zhang, Y. Honda, and A. Akaike. 2002. New insight into the functional role of acetylcholine in developing embryonic rat retinal neurons. Investig. Ophthalmol. Vis. Sci. 43:446-451.
51. Zaks, K., M. Jordan, A. Guth, K. Sellins, R. Kedl, A. Izzo, C. Bosio, and S.Dow. 2006. Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes. J. Immunol. 176:7335-7345.
52. Zelphati, O., and F. C. Szoka, Jr. 1996. Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. uSA 93:11493-11498.
53. Zychlinsky, A., J. J. Perdomo, and P. J. Sansonetti. 1994. Molecular and cellular mechanisms of tissue invasion by Shigella flexneri. Ann. N. Y. Acad. Sci. 15:197-208.